MedTech Companies

The acquisition gives Zimmer Biomet full ownership of the iovera° system, an FDA-cleared medical device that relieves pain without medication.

The OPUSWAVE Imaging System is built around Terumo’s DualView Imaging Catheter, which combines optical frequency-domain imaging (OFDI) and intravascular ultrasound (IVUS) on a single platform.

The combined business will operate as Cortigent Holdings and trade on Nasdaq under the ticker symbol CRGT once the transaction closes, expected in the third quarter of 2026, subject to shareholder and regulatory approvals.

The Jasper, Indiana-based electronics and medical contract manufacturer will add Helvoet’s facilities in Tilburg, the Netherlands, and in Pune, India, to its global manufacturing network.

Researchers can use the platform to design CRISPR screening experiments, analyse single-cell RNA sequencing data and generate three-dimensional protein structures, chemistry drawings and genome browser tracks.

Unlike conventional sequencing technologies, Axelios 1 uses SBX chemistry to convert DNA or RNA molecules into enlarged surrogate polymers known as Xpandomers.

BrightHeart will officially introduce the platform to European clinicians during the Fetal Medicine Foundation (FMF) World Congress in Vienna, taking place from June 28 to July 2, 2026.

Scientia Vascular develops advanced access products designed to improve simplicity and precision during neurovascular interventions.

Novanta plans to finance the acquisition using a combination of cash on hand, proceeds from a recently completed US$300 million equity raise, and its existing credit facilities.

The newly cleared technology aims to standardize routine ultrasound examinations, reduce variability between operators, and minimize the need for repeat scans.